Further, up-regulation of intra-hepatic CCR5 has been shown in fibrotic and cirrhotic livers [36, 37], while MIP-1β serum concentration was higher in individuals with chronic liver diseases compared to healthy controls and also was higher in cirrhotic individuals compared to those without cirrhosis [36]. This evidence concerns the gene CCR5 and Cirrhosis.